知镜 Cognispect · 医学文献与研究工作台

Diagnostic accuracy of CBCT versus digital radiography for early detection of peri-implant bone loss: a retrospective study with threshold and observer variability analysis.

Aljoghaiman E.
Frontiers in dental medicine · 2026-10-21 · PMID 42985655

文献摘要

Background Early peri-implant marginal bone loss is clinically important. Digital periapical radiography is routinely used but may have limited sensitivity for subtle osseous changes, whereas CBCT provides three-dimensional visualization. Objective To compare CBCT and digital periapical radiography for detecting peri-implant marginal bone loss and evaluate severity-specific sensitivity, observer agreement, and repeatability. Methods This retrospective diagnostic accuracy study included 130 implant sites from 100 patients evaluated between January 2018 and December 2025. Three observers independently assessed both modalities. The reference standard classified 73 sites as positive, 55 as negative, and 2 as inconclusive. Binary diagnostic accuracy was based on site-level majority voting (≥2 of 3 observers), while the mean continuous bone-loss measurement across observers was used for primary ROC analysis. Severity-specific sensitivity was assessed for ≤0.5 mm, >0.5-1 mm, and >1 mm bone loss. Interobserver agreement and intraobserver repeatability were evaluated. Patient-clustered generalized estimating equation (GEE) logistic regression accounted for within-patient clustering and repeated observer assessments. Results Among 128 evaluable sites, CBCT demonstrated higher sensitivity (97.3% vs. 78.1%) and accuracy (96.9% vs. 87.5%) than digital periapical radiography. Specificity, PPV, and NPV were 96.4%, 97.3%, and 96.4% for CBCT vs. 100.0%, 100.0%, and 77.5%, respectively. AUCs were 0.91 vs. 0.78 (DeLong p κ = 0.85 vs. 0.67) and intraobserver repeatability (ICC = 0.93 vs. 0.77) were higher with CBCT. CBCT was associated with higher odds of correct classification than digital periapical radiography (adjusted OR = 1.97, 95% CI: 1.16-3.34; p = 0.012). Conclusion CBCT showed superior diagnostic performance, particularly for smaller bone-loss lesions. However, radiographic changes of ≤0.5 mm should not be considered definitive evidence of biologically meaningful progression. CBCT should not be used for routine screening of asymptomatic implant sites but considered selectively when clinically justified. Prospective longitudinal studies are warranted.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。